Carcinoid Heart Disease Clinical Trial
Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors Carcinoid Heart Disease (CHD): An Observational French Multi-Centre Cohort Study CRUSOE - NETs (CaRdiac UltraSonic OutcomEs - NETs)
|Source||Hospices Civils de Lyon|
|Contact||Catherine LOMBARD-BOHAS, Dr|
|Phone||04 72 11 91 67|
|Status||Not yet recruiting|
|Start date||April 2018|
|Completion date||April 2033|
Carcinoid Heart Disease (CHD) is a rare form of heart disease, occurring in over 50% of the
patients with carcinoid syndrome. Pathophysiology, prognostic factors of development of
Carcinoid Heart Disease and progression of disease remain unclear.
This observational multicenter cohort study is designed to study the occurrence of Carcinoid Heart Disease in patients with differentiated carcinoid tumors, to describe numerous factors influencing the occurrence, severity, progression and long-term survival of patients with Carcinoid Heart Disease. Basic informations and detailed diagnosis informations (oncological and cardiac parameters), are collected by professional doctors. Clinical outcomes (onset of Carcinoid Heart Disease, cardiac surgery, related death) will be followed up every year or every six/three months if clinically indicated.